Maria Sunzel

514 total citations
17 papers, 425 citations indexed

About

Maria Sunzel is a scholar working on Molecular Biology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Maria Sunzel has authored 17 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in Maria Sunzel's work include Epilepsy research and treatment (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Maria Sunzel is often cited by papers focused on Epilepsy research and treatment (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Maria Sunzel collaborates with scholars based in Sweden, United States and United Kingdom. Maria Sunzel's co-authors include J. G. Riddell, I. Eriksson, Richard Hubner, Lars Berggren, Jan Jaap van Lier, Bengt Hamrén, Erik Björk, MO Karlsson, L Paalzow and C G Regårdh and has published in prestigious journals such as Gastroenterology, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

Maria Sunzel

17 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Sunzel Sweden 11 158 89 69 69 56 17 425
Nozomu Yoshimura Japan 16 84 0.5× 52 0.6× 77 1.1× 97 1.4× 29 0.5× 28 485
Brian N. C. Prichard United Kingdom 13 272 1.7× 112 1.3× 64 0.9× 85 1.2× 62 1.1× 18 542
WH Aellig Japan 9 202 1.3× 65 0.7× 66 1.0× 115 1.7× 62 1.1× 10 452
DA Richards United States 10 153 1.0× 35 0.4× 38 0.6× 104 1.5× 64 1.1× 21 367
BN Prichard United Kingdom 12 150 0.9× 47 0.5× 69 1.0× 84 1.2× 55 1.0× 17 380
Louis Wj Australia 14 150 0.9× 74 0.8× 133 1.9× 103 1.5× 80 1.4× 29 547
M. M. Reidenberg United States 12 80 0.5× 51 0.6× 133 1.9× 48 0.7× 70 1.3× 27 659
Brigitte Lecocq France 9 127 0.8× 37 0.4× 63 0.9× 50 0.7× 40 0.7× 15 325
Giudicelli Jf France 12 256 1.6× 56 0.6× 122 1.8× 66 1.0× 59 1.1× 77 543
K. Haglund Sweden 13 147 0.9× 58 0.7× 54 0.8× 31 0.4× 57 1.0× 24 361

Countries citing papers authored by Maria Sunzel

Since Specialization
Citations

This map shows the geographic impact of Maria Sunzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Sunzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Sunzel more than expected).

Fields of papers citing papers by Maria Sunzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Sunzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Sunzel. The network helps show where Maria Sunzel may publish in the future.

Co-authorship network of co-authors of Maria Sunzel

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Sunzel. A scholar is included among the top collaborators of Maria Sunzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Sunzel. Maria Sunzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gu, Chungang, Charles S. Elmore, Richard J. Lewis, et al.. (2018). Late-occurring and Long-circulating Metabolites of GABAA2,3 Receptor Modulator AZD7325 Involving Metabolic Cyclization and Aromatization: Relevance to MIST Analysis and Application for Patient Compliance. Drug Metabolism and Disposition. 46(3). 303–315. 14 indexed citations
2.
Yang, Li, Maria Sunzel, Peng Xu, et al.. (2015). Evaluation of the pharmacokinetics and safety of single and multiple ceftaroline fosamil infusions in healthy Chinese and Western subjects. International Journal of Clinical Pharmacology and Therapeutics. 53(8). 681–691. 10 indexed citations
3.
4.
Zhou, Diansong, Zheng‐Rong Lu, Maria Sunzel, Hongmei Xu, & Nidal Al‐Huniti. (2014). Population pharmacokinetic modelling to assess clinical drug-drug interaction between AZD7325 and midazolam. Journal of Clinical Pharmacy and Therapeutics. 39(4). 404–410. 7 indexed citations
5.
Edeki, Timi, et al.. (2014). Safety, local tolerability and pharmacokinetics of ceftaroline fosamil administered in a reduced infusion volume. British Journal of Clinical Pharmacology. 78(6). 1291–1297. 3 indexed citations
6.
Yang, Li, et al.. (2013). P115 Pharmacokinetics (PK) and safety of single and multiple intravenous (IV) infusions of ceftaroline fosamil in healthy Chinese subjects. International Journal of Antimicrobial Agents. 42. S78–S78. 2 indexed citations
7.
Zhou, Diansong, Maria Sunzel, Maria Ribadeneira, et al.. (2011). A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABAA receptor modulator – an in vitro and in vivo comparison. British Journal of Clinical Pharmacology. 74(1). 98–108. 10 indexed citations
8.
Hamrén, Bengt, Erik Björk, Maria Sunzel, & MO Karlsson. (2008). Models for Plasma Glucose, HbA1c, and Hemoglobin Interrelationships in Patients with Type 2 Diabetes Following Tesaglitazar Treatment. Clinical Pharmacology & Therapeutics. 84(2). 228–235. 50 indexed citations
9.
Andersson, Tommy, Eva Bredberg, Maria Sunzel, Madeleine Antonsson, & Lars Weidolf. (2000). Pharmacokinetics (PK) and effect on pentagastrin stimulated peak acid output (PAO) of omeprazole (O) and its 2 optical isomers, S-omeprazole/esomeprazole (E) and R-omeprazole (R-O). Gastroenterology. 118(4). A1210–A1210. 21 indexed citations
10.
Ericsson, Hans, et al.. (1999). Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. European Journal of Clinical Pharmacology. 55(1). 61–67. 55 indexed citations
11.
Andersson, Ove K., et al.. (1998). Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients. European Journal of Clinical Pharmacology. 54(7). 497–501. 18 indexed citations
12.
Hubner, Richard, et al.. (1997). Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers.. PubMed. 11 Suppl 2. S19–25. 78 indexed citations
13.
Lier, Jan Jaap van, et al.. (1997). Absorption, metabolism and excretion of 14C-candesartan and 14C-candesartan cilexetil in healthy volunteers.. PubMed. 11 Suppl 2. S27–8. 38 indexed citations
14.
Sunzel, Maria. (1989). Determination of midazolam and the α-hydroxy metabolite by gas chromatography in small plasma volumes. Journal of Chromatography B Biomedical Sciences and Applications. 491(2). 455–460. 18 indexed citations
15.
Sunzel, Maria, L Paalzow, Lars Berggren, & I. Eriksson. (1988). Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam.. British Journal of Clinical Pharmacology. 25(5). 561–569. 48 indexed citations
16.
Berggren, Lars, et al.. (1987). Changes in respiratory pattern after repeated doses of diazepam and midazolam in healthy subjects. Acta Anaesthesiologica Scandinavica. 31(8). 667–672. 31 indexed citations
17.
Paalzow, Lennart, et al.. (1987). Probenecid-induced accumulation of 5-hydroxyindoleacetic acid and homovanillic acid in rat brain. Journal of Pharmacy and Pharmacology. 39(9). 705–710. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nozomu Yoshimura Breakdown of academic impact, for papers by Brian N. C. Prichard Breakdown of academic impact, for papers by WH Aellig Breakdown of academic impact, for papers by DA Richards Breakdown of academic impact, for papers by BN Prichard Breakdown of academic impact, for papers by Louis Wj Breakdown of academic impact, for papers by M. M. Reidenberg Breakdown of academic impact, for papers by Brigitte Lecocq Breakdown of academic impact, for papers by Giudicelli Jf Breakdown of academic impact, for papers by K. Haglund
Rankless by CCL
2026